Date register of trial

Trials for date register in the RPCEC

Date of Registration Public title Sponsor State
2009-08-21 Zinc Supplement in ill persons with ataxia type SCA-2. CIDEM Registered
2009-08-20 Effectiveness and Safety of use ior LeukoCIM as prophylaxis and treatment of Neutropenia in patients with HIV / AIDS. CIMAB Registered
2009-07-24 Impact of the Granulocytes Colony-Stimulating Factor (ior-LeukoCIM) in primary and secondary prophylaxis and post chemotherapy and/or radiotherapy neutropenia in oncohematological pediatric patients. CIMAB Registered
2009-07-24 Safety assessment of Granulocyte Colony Stimulating Factor:ior LeukoCIM in oncohematologic patients.Phase IV study. CIMAB Registered
2009-07-10 Effectiveness and Safety of ior EPOCIM in patients with Chronic Renal Failure on dialysis methods. CIMAB Registered
2009-07-03 Amniotic Membrane Transplantation vs Conjunctival–Limbal Autograft for Primary Pterygium HHA Registered
2009-07-03 Impact of Recombinant Human Erythropoietin (ior EPO-CIM) in oncology pediatric patients with post chemo and /or radiotherapy. CIMAB Registered
2009-07-03 Impact of Human Recombinant Erithoropoietin (ior EPOCIM) in cancer patients with post Chemo and Radiotherapy induced anemia. CIMAB Registered
2009-07-03 Safety evaluation of Recombinant Human Erythropoietin ior EPOCIM in the treatment of patient with cerebral infarction acute. Study Stage I. CIMAB Registered outdated
2009-07-03 Therapeutic Equivalence between ior EPOCIM and EPO without albumin, for patients with Chronic Renal failure on Peritoneal dialysis methods.(Hemodialysis or peritoneal dialysis). CIMAB Registered
2009-05-29 rTMS-stroke-phase I CIREN Registered
2009-03-13 Clinical evaluation of the effect anti-inflammatory of the extract of Mangifera indica L. (Vimang®) in patients with diagnosis of Bronchial Asthma CQF Registered
2009-02-11 Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. CIGB Registered
2009-02-11 Recombinant IFN alpha-2b for relapsing –remitting multiple sclerosis. CIGB Registered
2008-09-12 Challenge study to determine the protective efficacy of a single oral dose of the attenuated 638 strain. FINLAY Registered
2010-12-17 Use of h-R3 monoclonal antibody and radiotherapy to treat patients with advanced epithelial head and neck tumors. CIM Registered
2010-12-17 NGcGM3/VSSP/Montanide ISA 51 vaccine for breast cancer IIa, IIb and IIIa surgically treated with positive ganglia and disease-free, Phase IIb/III. CIM Registered
2010-12-17 99mtc-marked 14f7 MAb in colon/rectum tumor, Phase II CIM Registered
2010-12-17 NGcGM3/VSSP/Montanide ISA 51 vaccine in metastatic breast cancer. Phase II CIM Registered
2009-02-11 Recombinant interferon alpha-2b in paranoid schizophrenia. CIGB Registered